These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 16234527

  • 1. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
    Choi JY, Lee KS, Kwon OJ, Shim YM, Baek CH, Park K, Lee KH, Kim BT.
    J Clin Oncol; 2005 Oct 20; 23(30):7654-9. PubMed ID: 16234527
    [Abstract] [Full Text] [Related]

  • 2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec 20; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 3. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
    Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T.
    Indian J Med Res; 2018 Mar 20; 147(3):256-262. PubMed ID: 29923514
    [Abstract] [Full Text] [Related]

  • 4. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
    Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.
    Clin Nucl Med; 2000 Nov 20; 25(11):882-7. PubMed ID: 11079584
    [Abstract] [Full Text] [Related]

  • 5. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007 Nov 20; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 6. Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer.
    Kim SY, Roh JL, Yeo NK, Kim JS, Lee JH, Choi SH, Nam SY.
    Ann Oncol; 2007 Oct 20; 18(10):1698-703. PubMed ID: 17716985
    [Abstract] [Full Text] [Related]

  • 7. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb 20; 28(2):108-11. PubMed ID: 15854393
    [Abstract] [Full Text] [Related]

  • 8. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer.
    De Wever W, Vankan Y, Stroobants S, Verschakelen J.
    Eur Respir J; 2007 May 20; 29(5):995-1002. PubMed ID: 17331966
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P, Perrone AM, Picchio M, Ghi T, Farsad M, Nanni C, Messa C, Meriggiola MC, Pelusi G, Al-Nahhas A, Rubello D, Fazio F, Fanti S.
    Nucl Med Commun; 2007 Aug 20; 28(8):589-95. PubMed ID: 17625380
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
    Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, Price D, Smith GJ, Schelleman T, McKay WJ, Sizeland A.
    Ann Surg; 2002 Aug 20; 236(2):208-17. PubMed ID: 12170026
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
    Kresnik E, Mikosch P, Gallowitsch HJ, Kogler D, Wiesser S, Heinisch M, Unterweger O, Raunik W, Kumnig G, Gomez I, Grünbacher G, Lind P.
    Eur J Nucl Med; 2001 Jul 20; 28(7):816-21. PubMed ID: 11504077
    [Abstract] [Full Text] [Related]

  • 12. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2009 Mar 20; 45(3):218-24. PubMed ID: 18804404
    [Abstract] [Full Text] [Related]

  • 13. The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): an analysis of 649 cases.
    Lin M, Ambati C.
    Lung Cancer; 2012 Jun 20; 76(3):344-9. PubMed ID: 22206598
    [Abstract] [Full Text] [Related]

  • 14. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, Lee LY, Kang CJ, Wong AM, Liao CT.
    J Clin Oncol; 2006 Sep 20; 24(27):4371-6. PubMed ID: 16983105
    [Abstract] [Full Text] [Related]

  • 15. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
    Krabbe CA, Pruim J, van der Laan BF, Rödiger LA, Roodenburg JL.
    Oral Oncol; 2009 Mar 20; 45(3):234-40. PubMed ID: 18715818
    [Abstract] [Full Text] [Related]

  • 16. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec 20; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 17. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
    Buchs NC, Bühler L, Bucher P, Willi JP, Frossard JL, Roth AD, Addeo P, Rosset A, Terraz S, Becker CD, Ratib O, Morel P.
    J Gastroenterol Hepatol; 2011 Apr 20; 26(4):657-62. PubMed ID: 21155879
    [Abstract] [Full Text] [Related]

  • 18. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.
    Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R.
    Ann Surg Oncol; 2006 Mar 20; 13(3):397-404. PubMed ID: 16485158
    [Abstract] [Full Text] [Related]

  • 19. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
    Koolen BB, Vrancken Peeters MJ, Aukema TS, Vogel WV, Oldenburg HS, van der Hage JA, Hoefnagel CA, Stokkel MP, Loo CE, Rodenhuis S, Rutgers EJ, Valdés Olmos RA.
    Breast Cancer Res Treat; 2012 Jan 20; 131(1):117-26. PubMed ID: 21935602
    [Abstract] [Full Text] [Related]

  • 20. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT, Kim JK, Kim DY, Ahn SH, Lee JD, Yun M, Rha SY, Chon CY, Han KH.
    Oncology; 2007 Jan 20; 72 Suppl 1():104-10. PubMed ID: 18087190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.